Octreotide treatment for sulfonylurea-induced hypoglycaemia

Bronwyn A L Crawford and Channa Perera
Med J Aust 2004; 180 (10): . || doi: 10.5694/j.1326-5377.2004.tb06064.x
Published online: 17 May 2004

Bronwyn A L Crawford,* Channa Perera

  • 1 Royal Prince Alfred Hospital and the University of Sydney, Sydney, NSW 2050
  • 2 Orange Base Hospital, Orange.


  • 1. Veitch PC, Clifton-Bligh RJ. Long-acting sulfonylureas — long acting hypoglycaemia. Med J Aust 2004; 180: 84-85. <eMJA full text>
  • 2. Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993; 76: 752-756.
  • 3. Braatvedt GD. Octreotide for the treatment of sulfonylurea-induced hypoglycaemia in type 2 diabetes. N Z Med J 1997; 110: 189-190.
  • 4. Graudins A, Linden CH, Ferm RP. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemia hypoglycemia. Am J Emerg Med 1997; 15: 95-96.
  • 5. Krentz AJ, Boyle PJ, Justice KM, et al. Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide. Diabetes Care 1993; 16: 184-186.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.